Connecting COPD Heterogeneity to Action: From Biomarkers to Biologic Therapy Decisions

Recorded: January 27, 2026

COPD is a heterogeneous and complex respiratory condition that continues to challenge clinicians in diagnosis, classification, and treatment. This webinar covers the latest recommendations from the 2026 Global Initiative for Chronic Obstructive Lung Disease Report and essential updates for clinicians to apply in practice.

Gain an in-depth understanding of COPD heterogeneity and practical strategies to optimize patient outcomes. Expert faculty explore case-based discussions, evidence-based updates, and clinical considerations designed to support personalized care pathways. Key focus areas include biologic therapy decisions, exacerbation risk reduction, and biomarker assessment—bridging the gap between guideline recommendations and real-world clinical application.

This is a nonpromotional, non-CME credit disease state educational program brought to you by CHEST in collaboration with and sponsored by GSK.